SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-20-005565
Filing Date
2020-06-10
Accepted
2020-06-10 07:05:29
Documents
2
Period of Report
2020-06-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_060920.htm 8-K 28323
2 PRESS RELEASE OF TONIX PHARMACEUTICALS HOLDING CORP., DATED JUNE 10, 2020 ex99-01.htm EX-99.01 20334
  Complete submission text file 0001387131-20-005565.txt   49983
Mailing Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 20953476
SIC: 2834 Pharmaceutical Preparations